Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Arkwright

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The British Journal of Dermatology|September 24, 2020
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension studyM J Cork, D Thaçi, L F Eichenfield, et al.
Clinical and Experimental Immunology|February 7, 2009
Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophyM Hong, K R Ryan, P D Arkwright, et al.
Journal of Clinical Immunology|February 10, 2015
Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across EuropeA J Turley, B Gathmann, C Bangs, et al.
The British Journal of Dermatology|October 10, 2019
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extensionM J Cork, D Thaçi, L F Eichenfield, et al.
Clinical and Experimental Immunology|June 8, 2018
The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017B Shillitoe, C Bangs, D Guzman, et al.
Blood|January 3, 2001
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.
Clinical and Experimental Immunology|July 12, 2013
The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012J D M Edgar, M Buckland, D Guzman, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The British Journal of Dermatology|September 24, 2020
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension studyM J Cork, D Thaçi, L F Eichenfield, et al.
Clinical and Experimental Immunology|February 7, 2009
Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophyM Hong, K R Ryan, P D Arkwright, et al.
Journal of Clinical Immunology|February 10, 2015
Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across EuropeA J Turley, B Gathmann, C Bangs, et al.
The British Journal of Dermatology|October 10, 2019
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extensionM J Cork, D Thaçi, L F Eichenfield, et al.
Clinical and Experimental Immunology|June 8, 2018
The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017B Shillitoe, C Bangs, D Guzman, et al.
Blood|January 3, 2001
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.
Clinical and Experimental Immunology|July 12, 2013
The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012J D M Edgar, M Buckland, D Guzman, et al.
Pageof 5